![]() |
|||||||||||||
|
N-Phenethyl-14-ethoxymetopon |
|
N-Phenethyl-14-ethoxymetopon
|
|
| Systematic (IUPAC) name | |
| 3-hydroxy-14-ethoxy-5-methyl-7,8-dihydro-4,5α-epoxy-17-(2-phenylethyl)morphinan-6-one | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C27H31NO4 |
| Mol. mass | 433.538 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
N-Phenethyl-14-ethoxymetopon is a drug which is a derivative of metopon. It is a potent analgesic, around 60 times stronger than morphine, but produces significantly less constipation.1
N-Phenethyl-14-ethoxymetopon acts as an agonist at both μ- and δ-opioid receptors, with a Ki of 0.16nM at μ and 3.14nM at δ.2